These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22646067)

  • 21. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of glycopyrrolate in the management of drooling.
    Stern LM
    J Paediatr Child Health; 1997 Feb; 33(1):52-4. PubMed ID: 9069045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
    Arbouw ME; Movig KL; Koopmann M; Poels PJ; Guchelaar HJ; Egberts TC; Neef C; van Vugt JP
    Neurology; 2010 Apr; 74(15):1203-7. PubMed ID: 20385892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions for drooling in children with cerebral palsy.
    Walshe M; Smith M; Pennington L
    Cochrane Database Syst Rev; 2012 Nov; 11():CD008624. PubMed ID: 23152263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose glycopyrrolate for clozapine-associated sialorrhea.
    Praharaj SK; Munoli RN; Sharma PS
    J Clin Psychopharmacol; 2014 Jun; 34(3):392. PubMed ID: 24717248
    [No Abstract]   [Full Text] [Related]  

  • 26. A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients.
    Jost WH; Steffen A; Berweck S
    Expert Rev Neurother; 2021 Oct; 21(10):1059-1068. PubMed ID: 34516331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticholinergic medications for reducing drooling in children with developmental disability.
    Reid SM; Westbury C; Guzys AT; Reddihough DS
    Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of drooling: 10 years after the Consortium on Drooling, 1990.
    Blasco PA
    Dev Med Child Neurol; 2002 Nov; 44(11):778-81. PubMed ID: 12418620
    [No Abstract]   [Full Text] [Related]  

  • 29. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
    Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
    Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term efficacy of glycopyrrolate on sialorrhea in Goldenhar syndrome: a case report.
    Della Bella G; Castelli E; Vigevano F
    Ital J Pediatr; 2022 Sep; 48(1):166. PubMed ID: 36068575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.
    Sridharan K; Sivaramakrishnan G
    J Clin Neurosci; 2018 May; 51():12-17. PubMed ID: 29475576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sialorrhea - therapeutic drug options.
    Tscheng DZ
    Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of glycopyrrolate/eFlow
    Kerwin E; Donohue JF; Goodin T; Tosiello R; Wheeler A; Ferguson GT
    Respir Med; 2017 Nov; 132():238-250. PubMed ID: 28838685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.
    Martinez FJ; Rabe KF; Lipworth BJ; Arora S; Jenkins M; Martin UJ; Reisner C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():99-106. PubMed ID: 32021148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Glycopyrrolate, an alternative to deptropine citratie when treating sialorrhea].
    Cosaert K; Willems L; Spriet I
    J Pharm Belg; 2010 Mar; (1):22-3. PubMed ID: 20429392
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis.
    Paller AS; Shah PR; Silverio AM; Wagner A; Chamlin SL; Mancini AJ
    J Am Acad Dermatol; 2012 Nov; 67(5):918-23. PubMed ID: 22405644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The when, why, and how of using glycopyrronium to diminish drooling in children with neurodevelopmental disabilities: Implications for clinical practice.
    Orriëns LB; van der Burg JJW; van den Hoogen FJA; Willemsen MAAP; van Hulst K; Erasmus CE
    Eur J Paediatr Neurol; 2024 Jul; 51():24-31. PubMed ID: 38776696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy.
    Dias BLS; Fernandes AR; Maia HS
    Arq Neuropsiquiatr; 2017 May; 75(5):282-287. PubMed ID: 28591387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycopyrrolate for clozapine-induced sialorrhea.
    Duggal HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1546-7. PubMed ID: 17614181
    [No Abstract]   [Full Text] [Related]  

  • 40. Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports.
    Agbi KE; Carvalho M; Vieira-Banov F
    Int J Pharm Compd; 2021; 25(6):464-467. PubMed ID: 34807840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.